Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Since the successful production of humanized antibodies in the 1980s, antibody-based medications have become increasingly essential in clinical treatment, taking advantage of their low immunogenicity ...

Roche researchers have set out how patient-derived organoids, automation and high-content imaging have combined within the ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...

Sygnature Discovery, an integrated drug discovery contract research organization (CRO), reports that it completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...

(Nanowerk Spotlight) Scientists manipulating living cells face a fundamental challenge: working with thousands of samples at the nanoliter scale – volumes measured in billionths of a liter. At this ...